These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10099105)

  • 21. Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection.
    Klein RS; Arnsten JH; Sobel JD
    J Infect Dis; 2000 Feb; 181(2):812-3. PubMed ID: 10669393
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of semen in HIV-1 transmission: inhibitor or facilitator?
    Doncel GF; Joseph T; Thurman AR
    Am J Reprod Immunol; 2011 Mar; 65(3):292-301. PubMed ID: 21087339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.
    Kazmi SH; Naglik JR; Sweet SP; Evans RW; O'Shea S; Banatvala JE; Challacombe SJ
    Clin Vaccine Immunol; 2006 Oct; 13(10):1111-8. PubMed ID: 16928883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection.
    Smith PD; Li L; Meng G
    J Infect Dis; 1999 May; 179 Suppl 3():S436-40. PubMed ID: 10099114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection.
    Williams SB; Flanigan TP; Artenstein AW; VanCott TC; Smith D; Mayer K; Koup RA
    J Infect Dis; 1999 May; 179(5):1310-2. PubMed ID: 10191415
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.
    Kaushic C; Ferreira VH; Kafka JK; Nazli A
    Am J Reprod Immunol; 2010 Jun; 63(6):566-75. PubMed ID: 20384619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut-homing Δ42PD1
    Cheung AKL; Kwok HY; Huang Y; Chen M; Mo Y; Wu X; Lam KS; Kong HK; Lau TCK; Zhou J; Li J; Cheng L; Kiat Lee B; Peng Q; Lu X; An M; Wang H; Shang H; Zhou B; Wu H; Xu A; Yuen KY; Chen Z
    Nat Microbiol; 2017 Oct; 2(10):1389-1402. PubMed ID: 28808299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.
    Márquez M; Fernández Gutiérrez del Álamo C; Girón-González JA
    World J Gastroenterol; 2016 Jan; 22(4):1433-48. PubMed ID: 26819512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
    Pope M; Haase AT
    Nat Med; 2003 Jul; 9(7):847-52. PubMed ID: 12835704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and adaptive mucosal immunity in protection against HIV infection.
    Bergmeier LA; Lehner T
    Adv Dent Res; 2006 Apr; 19(1):21-8. PubMed ID: 16672545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of route of immunization on mucosal immunity and protection.
    Lehner T; Wang Y; Ping L; Bergmeier L; Mitchell E; Cranage M; Hall G; Dennis M; Cook N; Doyle C; Jones I
    J Infect Dis; 1999 May; 179 Suppl 3():S489-92. PubMed ID: 10099126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis.
    Burgener A; McGowan I; Klatt NR
    Curr Opin Immunol; 2015 Oct; 36():22-30. PubMed ID: 26151777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
    Vitali D; Wessels JM; Kaushic C
    AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protective mucosal immunity and HIV-1 mucosal vaccine strategy].
    Huang Y; Huang XG; Xu JQ
    Bing Du Xue Bao; 2009 Jul; 25(4):318-22. PubMed ID: 19769168
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV immunopathogenesis.
    Brennan C; Porche DJ
    J Assoc Nurses AIDS Care; 1997; 8(4):7-22. PubMed ID: 9260148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mucosal immune system and HIV-1 infection.
    Veazey R; Lackner A
    AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of human beta-defensins in HIV infection.
    Weinberg A; Quiñones-Mateu ME; Lederman MM
    Adv Dent Res; 2006 Apr; 19(1):42-8. PubMed ID: 16672548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.